This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Edmiston, J. S. Articles by Lebman, D. A. Search for Related Content PubMed PubMed Citation Articles by Edmiston, J. S. Articles by Lebman, D. A.

Inability of Transforming Growth Factor-ß to Cause SnoN Degradation Leads to Resistance to Transforming Growth Factor-ß–Induced Growth Arrest in Esophageal Cancer Cells

¹ Department of Microbiology and Immunology; ² Philips Institute, Department of Biochemistry; and ³ Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia

Requests for reprints: Deborah A. Lebman, Department of Microbiology and Immunology, Virginia Commonwealth University, P.O. Box 980678, Richmond, VA 23298-0678. Phone: 804-827-0378; Fax: 804-828-8453; E-mail: dlebman{at}mail2.vcu.edu.

It is well established that loss of a growth inhibitory response to transforming growth factor-ß (TGF-ß) is a common feature of epithelial cancers including esophageal cancer. However, the molecular basis for the abrogation of this key homeostatic mechanism is poorly understood. In esophageal cancer cell lines that are resistant to TGF-ß–induced growth inhibition, TGF-ß also fails to decrease transcription of c-myc despite the presence of functional signaling components. Consequently, to gain a better understanding of the mechanisms leading to resistance to TGF-ß–induced growth arrest, the basis for the inability to decrease c-myc transcription was investigated. Regardless of sensitivity to TGF-ß–induced growth arrest, TGF-ß enhanced the ability of Smad3-protein complexes to bind c-myc regulatory elements. However, in a growth inhibition–resistant esophageal cancer cell line, the Smad3-protein complexes contained the SnoN oncoprotein. Furthermore, in esophageal cancer cell lines that are resistant to TGF-ß–induced growth arrest, TGF-ß does not cause degradation of SnoN. Analyses of the effect of modulating SnoN expression in both growth inhibition–sensitive and growth inhibition–resistant cell lines showed that degradation of SnoN is a prerequisite for both TGF-ß–induced repression of c-myc transcription and growth arrest. The data indicate that SnoN-Smad3 complexes do not cause repression of c-myc transcription but rather prevent functionality of active repressor complexes. Thus, these studies reveal a novel mechanism for resistance to TGF-ß–induced growth inhibition in esophageal cancer, namely the failure to degrade SnoN. In addition, they show that SnoN can block TGF-ß repression of gene transcription.

This article has been cited by other articles:

				A. V. Miller, S. E. Alvarez, S. Spiegel, and D. A. Lebman Sphingosine Kinases and Sphingosine-1-Phosphate Are Critical for Transforming Growth Factor {beta}-Induced Extracellular Signal-Regulated Kinase 1 and 2 Activation and Promotion of Migration and Invasion of Esophageal Cancer Cells Mol. Cell. Biol., June 15, 2008; 28(12): 4142 - 4151. [Abstract] [Full Text] [PDF]

				L. Levy, M. Howell, D. Das, S. Harkin, V. Episkopou, and C. S. Hill Arkadia Activates Smad3/Smad4-Dependent Transcription by Triggering Signal-Induced SnoN Degradation Mol. Cell. Biol., September 1, 2007; 27(17): 6068 - 6083. [Abstract] [Full Text] [PDF]

				Q. Zhu, A. R. Krakowski, E. E. Dunham, L. Wang, A. Bandyopadhyay, R. Berdeaux, G. S. Martin, L. Sun, and K. Luo Dual Role of SnoN in Mammalian Tumorigenesis Mol. Cell. Biol., January 1, 2007; 27(1): 324 - 339. [Abstract] [Full Text] [PDF]

				Y.-H. R. Hsu, K. P. Sarker, I. Pot, A. Chan, S. J. Netherton, and S. Bonni Sumoylated SnoN Represses Transcription in a Promoter-specific Manner J. Biol. Chem., November 3, 2006; 281(44): 33008 - 33018. [Abstract] [Full Text] [PDF]

				H. Miyazaki, V. Patel, H. Wang, R. K. Edmunds, J. S. Gutkind, and W. A. Yeudall Down-regulation of CXCL5 Inhibits Squamous Carcinogenesis. Cancer Res., April 15, 2006; 66(8): 4279 - 4284. [Abstract] [Full Text] [PDF]

				M. D. Lacher, M. I. Tiirikainen, E. F. Saunier, C. Christian, M. Anders, M. Oft, A. Balmain, R. J. Akhurst, and W. M. Korn Transforming Growth Factor-{beta} Receptor Inhibition Enhances Adenoviral Infectability of Carcinoma Cells via Up-Regulation of Coxsackie and Adenovirus Receptor in Conjunction with Reversal of Epithelial-Mesenchymal Transition Cancer Res., February 1, 2006; 66(3): 1648 - 1657. [Abstract] [Full Text] [PDF]

				A. R. Krakowski, J. Laboureau, A. Mauviel, M. J. Bissell, and K. Luo From the Cover: Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-{beta} signaling by sequestration of the Smad proteins PNAS, August 30, 2005; 102(35): 12437 - 12442. [Abstract] [Full Text] [PDF]